| Literature DB >> 27624324 |
Karl Mrak1, Carolin Lackner2, Hans-Jörg Mischinger3, Peter Kornprat3.
Abstract
Renal cell carcinoma (RCC) represents a rare tumor entity accounting for approximately 3 % of all malignancies in the adult population. Approximately 30 % of all patients suffering from RCC develop metastases after nephrectomy and another 30 % of patients suffer from synchronous metastases at the date of diagnosis. Gallbladder metastases represent an extremely rare clinical condition and up to date there are only 35 published cases of gallbladder metastasis from RCC. Surgical resection should be the treatment of choice in any case based on the reported data in literature. In spite of the small series of cases, survival can be improved even in patients suffering from additional sites of metastases.Entities:
Keywords: Gallbladder; Metachronous neoplasms; Neoplasm metastases; Renal cell carcinoma; Therapeutics
Mesh:
Year: 2016 PMID: 27624324 DOI: 10.1007/s00508-016-1058-x
Source DB: PubMed Journal: Wien Klin Wochenschr ISSN: 0043-5325 Impact factor: 1.704